029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
UBD803膀胱癌及膀胱组织组合芯片,附TNM和临床分期,40例/80点
点 数80例 数40
行 数8列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:UBD803
 
膀胱癌及膀胱组织组合微阵列芯片,包含30例尿路上皮癌,10例边缘或癌旁组织,一例两点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Bla
-Bladder
 
AT (*)
 
Malignant (I)
 
Malignant (II)
 
Malignant (IIIA)
 
NAT (*)
TISSUE  ARRAYS UBD803
1
2
3
4
5
6
7
8
9
10
A
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
B
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
C
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
D
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
E
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
F
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
G
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
H
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1172MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*5*2.5N
A2272MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*5*2.5N
A3350MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
A4450MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
A5571MBladderLow-grade urothelial carcinoma*T2bN0M0IIMalignant4.5*3*2N
A6671MBladderLow-grade urothelial carcinoma*T2bN0M0IIMalignant4.5*3*2N
A7770MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*4*4N
A8870MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*4*4N
A9958MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant8*7*5N
A101058MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant8*7*5N
B11159FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
B21259FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
B31337FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*5*2.5N
B41437FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*5*2.5N
B51567MBladderLow-grade urothelial carcinoma*T2aN0M0IIMalignant3*1*0.5N
B61667MBladderLow-grade urothelial carcinoma*T2aN0M0IIMalignant3*1*0.5N
B71751MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
B81851MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
B91979FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant*N
B102079FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant*N
C12145FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
C22245FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
C32361MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant*N
C42461MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant*N
C52556FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant6*5*0.5N
C62656FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant6*5*0.5N
C72770MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*7*5N
C82870MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*7*5N
C92955MBladderLow-grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
C103055MBladderLow-grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
D13165MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant*N
D23265MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant*N
D33352MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant6*5*2N
D43452MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant6*5*2N
D53542MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
D63642MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
D73743FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
D83843FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
D93957FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant6*4*4N
D104057FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant6*4*4N
E14156MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
E24256MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
E34333MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant*N
E44433MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant*N
E54553MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant11*8*4N
E64653MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant11*8*4N
E74744MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E84844MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E94970MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant5*4*3N
E105070MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant5*4*3N
F15142MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
F25242MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
F35360FBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant3*2N
F45460FBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant3*2N
F55535MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
F65635MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
F75766MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
F85866MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
F95950FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
F106050FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
G16163MBladderCancer adjacent bladder tissue***AT*N
G26263MBladderCancer adjacent bladder tissue***AT*N
G36351MBladderAdjacent normal bladder tissue***NAT*N
G46451MBladderAdjacent normal bladder tissue***NAT*N
G56575MBladderCancer adjacent bladder tissue***AT*N
G66675MBladderCancer adjacent bladder tissue***AT*N
G76771MBladderCancer adjacent bladder tissue***AT*N
G86871MBladderCancer adjacent bladder tissue***AT*N
G96968MBladderCancer adjacent bladder tissue***AT*N
G107068MBladderCancer adjacent bladder tissue***AT*N
H17149FBladderCancer adjacent bladder tissue***AT*N
H27249FBladderCancer adjacent bladder tissue***AT*N
H37377MBladderAdjacent normal bladder tissue***NAT*N
H47477MBladderAdjacent normal bladder tissue***NAT*N
H57560MBladderCancer adjacent bladder tissue***AT*N
H67660MBladderCancer adjacent bladder tissue***AT*N
H77751MBladderAdjacent normal bladder tissue***NAT*N
H87851MBladderAdjacent normal bladder tissue***NAT*N
H97955MBladderAdjacent normal bladder tissue***NAT*N
H108055MBladderAdjacent normal bladder tissue***NAT*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情